Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/b5/b2/be/b5b2be00-91d7-fc77-aa67-b6e7a4cb6366/mza_13779007793555969879.png/600x600bb.jpg
Beats Roundtable
Wall Street Beats
54 episodes
9 months ago
Show more...
Investing
Business
RSS
All content for Beats Roundtable is the property of Wall Street Beats and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Investing
Business
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/b5/b2/be/b5b2be00-91d7-fc77-aa67-b6e7a4cb6366/mza_13779007793555969879.png/600x600bb.jpg
Navigating a Slow Start to Q1 I Feb 18, 2025
Beats Roundtable
38 minutes 42 seconds
9 months ago
Navigating a Slow Start to Q1 I Feb 18, 2025
In this episode Beats Roundtable, Wall Street Beats pros David Maris, Robert Marcin, and Charlie Peabody dive into key market trends, covering the latest developments in banking, biotech, and retail. They discuss sluggish bank fundamentals, Wells Fargo’s growth strategy, Citi’s valuation boost, and Goldman Sachs’ risk exposure. Plus, insights on biotech movers like Ultragenyx and Teva, along with a deep dive into American Eagle’s stock potential.
Beats Roundtable